Strs Ohio Acquires Shares of 14,271 Amedisys, Inc. (NASDAQ:AMED)

Strs Ohio acquired a new stake in shares of Amedisys, Inc. (NASDAQ:AMED) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 14,271 shares of the health services provider’s stock, valued at approximately $1,356,000.

Other hedge funds have also recently bought and sold shares of the company. Contravisory Investment Management Inc. acquired a new stake in Amedisys during the 4th quarter valued at approximately $258,000. Argonautica Private Wealth Management Inc. grew its position in shares of Amedisys by 6.1% in the 3rd quarter. Argonautica Private Wealth Management Inc. now owns 3,003 shares of the health services provider’s stock worth $280,000 after acquiring an additional 172 shares in the last quarter. MRP Capital Investments LLC acquired a new position in shares of Amedisys in the 3rd quarter worth approximately $337,000. Commonwealth Equity Services LLC grew its position in shares of Amedisys by 2.9% in the 3rd quarter. Commonwealth Equity Services LLC now owns 3,896 shares of the health services provider’s stock worth $364,000 after acquiring an additional 110 shares in the last quarter. Finally, Xponance Inc. grew its position in shares of Amedisys by 3.2% in the 3rd quarter. Xponance Inc. now owns 4,076 shares of the health services provider’s stock worth $381,000 after acquiring an additional 125 shares in the last quarter. Institutional investors and hedge funds own 94.36% of the company’s stock.

Amedisys Trading Up 0.9 %

Shares of NASDAQ AMED opened at $91.24 on Tuesday. The company has a market cap of $2.98 billion, a price-to-earnings ratio of -294.31, a price-to-earnings-growth ratio of 4.25 and a beta of 0.86. Amedisys, Inc. has a 12-month low of $73.10 and a 12-month high of $96.44. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.32. The stock’s 50 day simple moving average is $92.72 and its 200 day simple moving average is $93.40.

Amedisys (NASDAQ:AMED) last announced its quarterly earnings results on Wednesday, February 21st. The health services provider reported $0.94 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.04 by ($0.10). The company had revenue of $570.79 million during the quarter, compared to the consensus estimate of $566.85 million. Amedisys had a positive return on equity of 12.76% and a negative net margin of 0.44%. The company’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same period last year, the business posted $1.16 EPS. Equities research analysts expect that Amedisys, Inc. will post 4.54 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. StockNews.com assumed coverage on Amedisys in a research report on Monday, April 8th. They issued a “buy” rating for the company. Raymond James reiterated a “market perform” rating on shares of Amedisys in a research report on Tuesday, March 26th. Finally, Royal Bank of Canada lifted their target price on Amedisys from $97.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, March 25th. Seven equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $97.50.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.